Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
255.60
+8.54 (3.46%)
At close: Nov 4, 2026, 4:00 PM EST
256.50
+0.90 (0.35%)
After-hours: Nov 4, 2026, 7:01 PM EST
Quest Diagnostics Revenue
Quest Diagnostics had revenue of $3.10B in the quarter ending September 30, 2026, with 9.98% growth. This brings the company's total for the last twelve months to $11.84B, up 9.13% year-over-year. In the year 2025, Quest Diagnostics had annual revenue of $11.04B with 11.78% growth. That makes Quest Diagnostics the 1,275th largest company in the world by revenue and 409th in the United States.
Revenue (ttm)
$11.84B
Revenue Growth
+9.13%
P/S Ratio
2.37
Revenue / Employee
$207,737
Employees
57,000
Market Cap
28.12B
Revenue by Segment
- Diagnostic Information Services (DIS) Business 10.79B 97.7%
- All Other Operating Segment 250.00M 2.3%
Fiscal year ended Dec 31, 2025 See the full Quest Diagnostics breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.04B | 1.16B | 11.78% |
| Dec 31, 2024 | 9.87B | 620.00M | 6.70% |
| Dec 31, 2023 | 9.25B | -631.00M | -6.38% |
| Dec 31, 2022 | 9.88B | -905.00M | -8.39% |
| Dec 31, 2021 | 10.79B | 1.35B | 14.32% |
| Dec 31, 2020 | 9.44B | 1.71B | 22.15% |
| Dec 31, 2019 | 7.73B | 195.00M | 2.59% |
| Dec 31, 2018 | 7.53B | 129.00M | 1.74% |
| Dec 31, 2017 | 7.40B | -113.00M | -1.50% |
| Dec 31, 2016 | 7.52B | 22.00M | 0.29% |
| Dec 31, 2015 | 7.49B | 58.00M | 0.78% |
| Dec 31, 2014 | 7.44B | 289.00M | 4.04% |
| Dec 31, 2013 | 7.15B | -237.00M | -3.21% |
| Dec 31, 2012 | 7.38B | -9.00M | -0.12% |
| Dec 31, 2011 | 7.39B | 131.88M | 1.82% |
| Dec 31, 2010 | 7.26B | -195.12M | -2.62% |
| Dec 31, 2009 | 7.46B | 205.80M | 2.84% |
| Dec 31, 2008 | 7.25B | 544.54M | 8.12% |
| Dec 31, 2007 | 6.70B | 436.25M | 6.96% |
| Dec 31, 2006 | 6.27B | 811.93M | 14.88% |
| Dec 31, 2005 | 5.46B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| IQVIA Holdings | 17.31B |
| Labcorp Holdings | 14.59B |
| ICON Public Limited Company | 8.23B |
| Agilent Technologies | 7.37B |
| Waters | 4.64B |
| Illumina | 4.54B |
| Mettler-Toledo International | 4.13B |
| Charles River Laboratories International | 4.00B |
DGX News
- 5 days ago - The big winners of the tech wreck are biopharma stocks - Market Watch
- 12 days ago - Lab testing giant Quest Diagnostics confirms patients' personal and health data was compromised during breach - TechCrunch
- 12 days ago - Quest Diagnostics price target raised to $262 from $260 at Baird - TheFly
- 12 days ago - Quest Diagnostics price target raised to $262 from $260 at Baird - TheFly
- 13 days ago - Quest Diagnostics discloses breach after ‘unauthorized access’ - TheFly
- 13 days ago - Quest Diagnostics Earnings Call Transcript: Q3 2026 - Transcripts
- 13 days ago - Quest Diagnostics Earnings release: Q3 2026 - Filings
- 13 days ago - Quest Diagnostics Slides: Q3 2026 - Filings